U.S. markets open in 2 hours 14 minutes

Agile Therapeutics, Inc. (AGRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.9700+0.1100 (+3.85%)
At close: 4:00PM EST

2.9900 +0.02 (0.67%)
Before hours: 6:24AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close2.8600
Open2.8500
Bid0.0000 x 3100
Ask0.0000 x 4000
Day's Range2.8500 - 2.9900
52 Week Range1.3500 - 4.7650
Volume1,285,723
Avg. Volume914,688
Market Cap260.172M
Beta (5Y Monthly)1.33
PE Ratio (TTM)N/A
EPS (TTM)-0.5130
Earnings DateFeb 18, 2021 - Feb 22, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
    GlobeNewswire

    Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference

    PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will participate in a fireside chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference. The fireside chat will be available for on-demand listening beginning Monday, January 11, 2021, at 6:00 AM Eastern Time on the Investors section of the Agile Therapeutics website at www.agiletherapeutics.com, under the Events & Presentations tab. The archived webcast will be available for 30 days.About Agile Therapeutics, Inc. Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women.  Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.  Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.Follow Agile on LinkedIn and Twitter: @AgileTher.Contact:   Matt Riley Head of Investor Relations & Corporate Communications mriley@agiletherapeutics.com

  • Are Institutions Heavily Invested In Agile Therapeutics, Inc.'s (NASDAQ:AGRX) Shares?
    Simply Wall St.

    Are Institutions Heavily Invested In Agile Therapeutics, Inc.'s (NASDAQ:AGRX) Shares?

    A look at the shareholders of Agile Therapeutics, Inc. ( NASDAQ:AGRX ) can tell us which group is most powerful...

  • Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
    GlobeNewswire

    Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

    PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the Company will present at the 39th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on Thursday, January 14, 2021, at 9:10 a.m. ET. A live webcast of the presentation will be available in the Events and Presentations section of the Agile Therapeutics Investor Relations page. The archived webcast will be available for 30 days.About Agile Therapeutics, Inc. Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women.  Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.  Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.Follow Agile on LinkedIn and Twitter: @AgileTher.Contact:   Matt Riley Head of Investor Relations & Corporate Communications mriley@agiletherapeutics.com